“…PERK commands a slightly different pathway for this purpose, it enforces translational inhibition of IκB thereby freeing NF-κB for engaging its transcriptional program (Blais et al, 2006;Halliday et al, 2017;Pytel et al, 2016;Qiao et al, 2017;Tam et al, 2012). Lastly, although ATF6 axis has been shown to influence NF-κB activation yet, the exact mechanism underlying this cascade has not been established (Tam et al, 2018;Yamazaki et al, 2009). Similar to NF-κB, AP1 is an important inflammatory transcription factor composed of monomers of a variety of proteins, like Jun proto-oncogene or JUN, Fos proto-oncogene or FOS, ATF and/or, musculoaponeurotic fibrosarcoma (MAF) (Uluçkan et al, 2015;van Dam and Castellazzi, 2001;Wagner, 2010).…”